U.K. Medicines And Healthcare Products Regulatory Agency Authorizes Eli Lilly's Onswik For Adults With Type 2 Diabetes
https://www.gov.uk/government/news/mhra-authorises-onswik-insulin-efsitora-alfa-for-adults-with-type-2-diabetes
Share
Why It Matters
Eli Lilly got approval in the U.K. to sell a new diabetes medicine. This shows the company is growing its medicine choices for patients.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.